154 related articles for article (PubMed ID: 3368123)
1. Antibodies to ganglioside GM1 in patients with Alzheimer's disease.
Chapman J; Sela BA; Wertman E; Michaelson DM
Neurosci Lett; 1988 Mar; 86(2):235-40. PubMed ID: 3368123
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against gangliosides in patients with dementia.
Hatzifilippou E; Koutsouraki E; Costa VG; Baloyannis SJ
Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):660-6. PubMed ID: 24838532
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease.
Miura Y; Miyaji K; Chai YL; Chen CL; Lai MK; Yuki N
J Alzheimers Dis; 2014; 42(4):1165-9. PubMed ID: 25024341
[TBL] [Abstract][Full Text] [Related]
4. The probable auto-antigenic role of lipids (anti-ganglioside antibodies) in the pathogenesis of Alzheimer's disease.
Koutsouraki E; Hatzifilippou E; Michmizos D; Banaki T; Costa V; Baloyannis S
J Alzheimers Dis; 2014; 42 Suppl 3():S163-6. PubMed ID: 24898654
[TBL] [Abstract][Full Text] [Related]
5. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
6. Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.
Ariga T; Kubota M; Nakane M; Oguro K; Yu RK; Ando S
PLoS One; 2013; 8(5):e63326. PubMed ID: 23717411
[TBL] [Abstract][Full Text] [Related]
7. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against GM1 in demented patients.
Hatzifilippou E; Koutsouraki E; Banaki T; Traka M; Costa VG; Baloyannis SJ
Am J Alzheimers Dis Other Demen; 2008; 23(3):274-9. PubMed ID: 18509104
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody reactivity in serum of patients with Alzheimer's disease and other age-related dementias.
Schott K; Wormstall H; Dietrich M; Klein R; Batra A
Psychiatry Res; 1996 Jan; 59(3):251-4. PubMed ID: 8930031
[TBL] [Abstract][Full Text] [Related]
11. [Antibodies to GM1 and GQ1b gangliosides].
Obayashi H; Nishimura M; Saida T; Hasegawa G; Nakamura N; Kondo M
Nihon Rinsho; 1999 Nov; 57 Suppl():561-3. PubMed ID: 10635912
[No Abstract] [Full Text] [Related]
12. Gangliosides in Neurodegenerative Diseases.
Ledeen R; Chowdhury S
Adv Neurobiol; 2023; 29():391-418. PubMed ID: 36255682
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia.
Shy ME; Evans VA; Lublin FD; Knobler RL; Heiman-Patterson T; Tahmoush AJ; Parry G; Schick P; DeRyk TG
Ann Neurol; 1989 May; 25(5):511-3. PubMed ID: 2505666
[TBL] [Abstract][Full Text] [Related]
14. Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.
Blennow K; Davidsson P; Wallin A; Fredman P; Gottfries CG; Månsson JE; Svennerholm L
Aging (Milano); 1992 Dec; 4(4):301-6. PubMed ID: 1294245
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
16. Anti-ganglioside complex antibodies associated with severe disability in GBS.
Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
18. Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum.
Fukami Y; Wong AH; Funakoshi K; Safri AY; Shahrizaila N; Yuki N
Eur J Neurol; 2016 Feb; 23(2):320-6. PubMed ID: 26176883
[TBL] [Abstract][Full Text] [Related]
19. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
[TBL] [Abstract][Full Text] [Related]
20. Regenerative capacity of the goldfish visual system is affected by antibodies specific to gangliosides injected intraocularly.
Spirman N; Sela BA; Gitler C; Calef E; Schwartz M
J Neuroimmunol; 1984 Jun; 6(3):197-207. PubMed ID: 6725551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
